Glycan Therapeutics LLC SBIR Phase II Award, July 2019
A SBIR Phase II contract was awarded to Glycan Therapeutics in July, 2019 for $1,244,412.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
1,244,412
0
Government Branch
Date Awarded
July 4, 2019
0
End Date
June 30, 2021
0
SBIR/STTR Award Recipient
Contract Number (US Government)
2R44HL139187-02
0
Award Phase
Phase II
0
Award Type
SBIR
0
Official Website
Find more entities like Glycan Therapeutics LLC SBIR Phase II Award, July 2019
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.